Founders

Igal Liapis
B Pharm. MBA - CEO

Igal Liapis
B Pharm. MBA - CEO
An MBA pharmacist with over 25 years of experience in pharmaceutical entrepreneurship and a track-record of co-founding and managing successful firms such as Tree of Life Pharma Ltd. and Prudentix Ltd

Danny Rosenbaum
B Pharm, MBA - VP Regulatory Affairs

Danny Rosenbaum
B Pharm, MBA - VP Regulatory Affairs
An MBA pharmacist with 25 years of experience in the regulatory affairs field of medical devices and pharmaceuticals. Co-founder of several medical companies. Mr. Rosenbaum has been working for many years as a regulatory consultant of medical devices and pharmaceuticals

Dr. Dadi Segal
PhD, B Pharm., MBA. - VP Business Development

Dr. Dadi Segal
PhD, B Pharm., MBA. - VP Business Development
Dr. Segal has over 25 years of entrepreneurship experience and a track-record as co-founder of seven successful pharmaceutical and medical device companies collectively employing over 400 people, selling products in 50+ countries and generating multimillion dollar sales. Successfully exited three companies through high value acquisitions by major pharmaceutical firms.
Dr. Segal earned his doctorate in Computational Chemistry and Masters in Bioinformatics at the Weizmann Institute in Rehovot Israel
Scientific Team

Dr. Franco Cavalla
DDS, Periodontist, MSc, PhD, Advisor

Dr. Franco Cavalla
DDS, Periodontist, MSc, PhD, Advisor
Dr. Franco Cavalla earned his Doctor of Dental Surgery (DDS) in 2004 and completed his clinical specialization in periodontics in 2009. By 2018, he had also obtained a Master’s degree and a PhD in osteoimmunology and biomaterials. His research experience spans Chile, Brazil, and the United States. Since 2024, he has served as a full professor at Universidad Andrés Bello in Chile and is the head of the Bone Biology and Bone Regeneration Laboratory at the School of Dentistry. Dr. Cavalla's research centers on immunomodulatory mechanisms involved in bone healing and regeneration. He has secured funding from several sources, including Universidad Andrés Bello, the Chilean Fund for Research Development, the Oral Regeneration Foundation, and the State of São Paulo Research Foundation. Additionally, he has authored or co-authored over 56 peer-reviewed scientific articles and two book chapters.

Prof. Roni Kolerman
DMD, PhD, advisor

Prof. Roni Kolerman
DMD, PhD, advisor
Prof. Kolerman is finished his post-graduation studies in periodontology, Hadassah dental school, the Hebrew University in 1998.
Member of the Israeli and European society of periodontology.
Published over 60 articles in leading periodontal and implant dentistry journals. Main fields of research are immediate loading, histomorphometry, and advanced bone augmentation techniques.
Academic Professor in the periodontal department of Tel Aviv University.
Private practice limited to periodontics and implant dentistry in Tel Aviv.

Dr. Ariel Hirsch
DMD, Advisor

Dr. Ariel Hirsch
DMD, Advisor
Dr Ariel Hirsch is a well known specialist in periodontology, with international activities academically and clinically. Dr. Hirsch published and lectured in international journals and conferences about periodontal treatment and implant therapy in dental and oral disease.
Member EFP- European Federation of Periodontology,
Member AAP- American Association of Periodontology,
Member ISP- Israel Society of Periodontology
ISP President 2012-2013

Prof. David Polak
DMD, PhD, advisor

Prof. David Polak
DMD, PhD, advisor
Prof. David Polak is a lecturer at the dept. of periodontology at the Hebrew University Hadassah Faculty of Dental Medicine .He graduated from the Hebrew University-Hadassah Faculty of Dental Medicine in 2004 and completed the graduate program in Periodontics in 2010 at the same institution and holds an EFP periodontist credential.
Currently, Dr. Polak is a senior instructor and researcher in basic science at the Department of Periodontology, Hadassah medical center.
His studies focus mainly on the pathogenesis of periodontal disease and neutrophil biology. Additional studies focus on biofilm models on teeth and implant surfaces as well as on the biology of osteoblast in processes of re-osseointegration in peri-implantitis models. Dr. Polak received several awards for his scientific and clinical achievements. He has published extensively in the dental and periodontal literature and is an invited speaker in national and international conferences.

Dr. Meizi Eliezer
DMD, MSc, BMS, Advisor

Dr. Meizi Eliezer
DMD, MSc, BMS, Advisor
Dr. Meizi Eliezer DMD MAS MSC. Completed her specialisation in Periodontology and Implantology at the University of Bern, Switzerland. She has EFP accreditation and runs a private periodontal and implant clinic in Herzliya, Israel. Dr. Meizi is internationally recognized for her clinical expertise, research, and lectures on periodontal regeneration and soft tissue surgery. She is passionate about preserving teeth, advancing evidence-based dentistry, and educating professionals worldwide.

Dr. Amir Haze
PhD, MD - Medical Advisor

Dr. Amir Haze
PhD, MD - Medical Advisor
Senior orthopedic surgeon, subspecializing in foot and ankle surgery, Orthopedic Surgery Department, Hadassah University Hospital, Ein Kerem, Jerusalem, Israel. Dr. Haze’s PhD dissertation focused on the roles of amelogenins during the development and the regeneration of mesenchymal tissues (bone, cartilage and periodontal ligament). Dr. Haze is a member of the American Orthopedic Foot and Ankle Society.

Dr. Hagit Sacks
PhD - VP Research & Development

Dr. Hagit Sacks
PhD - VP Research & Development
Dr. Sacks brings over 18 years of experience in R&D and medical device development, from the stage of raw materials to pre-clinical and clinical studies. Before joining Prudentix, Dr. Sacks served as VP of R&D at PhytoTech Therapeutics (cannabinnoids derived Rx oral drugs), Director of Pharmaceutical R&D at Nicast (medical devices made of electrospun polymer nanofabrics), and in lead positions at TransPharma Medical (a combination drug-device transdermal delivery).